Skip to main content
    The obesity clinic
    Menu closed
    Guidelines
    GLP-1
    Safety

    Published 15 January 2025 · 8 minutes reading time

    GLP-1 Guidelines 2026: What You Need to Know

    Swedish National Board of Health and Welfare and international guidelines for safe prescribing of GLP-1 analogs for obesity and type 2 diabetes.

    GLP-1 guidelines 2026 - Medical documentation and guidelines

    Quick answer

    The Swedish National Board of Health and Welfare and international guidelines require individual medical assessment by a licensed physician before GLP-1 initiation. All patients must undergo medical history, laboratory tests, and discussion of treatment goals, with planned follow-ups after approximately 4, 12, and 24 weeks.

    DD

    Dr. Dorél Lehrer

    Licensed Physician

    Medical Director at Viktenheten
    Experienced in medical weight management

    Verifierad av Socialstyrelsen

    Medicinskt granskad: 15 January 2025

    During 2024–2025, several national and international authorities have updated their recommendations on GLP-1 analogs. Here we summarize the most important points for patients and healthcare providers.

    Requirements for Medical Assessment Before Starting

    All patients must undergo an individual assessment by a licensed physician. The assessment should include medical history, current medications, laboratory tests, and discussion of treatment goals.

    We Go Through Every Step Together

    We go through every step together and ensure you feel confident before starting treatment.

    The Prescription Process Step by Step

    • Digital triage: You fill in medical background, medications, and goals in a secure form.
    • Video visit with licensed physician: During the video meeting, we make the clinical assessment.
    • Multidisciplinary plan: Dietitian, physiotherapist, or psychologist are brought in based on needs.
    • Treatment start: Dose titration is documented in writing along with contact routes.

    Follow-up According to 2025 Guidelines

    • Scheduled check-ins: Follow-ups after approximately 4, 12, and 24 weeks.
    • Interim messages via patient portal: You can always write to us between visits.
    • Documented weight goal: We set a realistic goal together.
    • Reassessment as needed: In case of pregnancy or side effects, we make a new assessment.

    Common Side Effects and Action Plans

    • Transient nausea and appetite satiety
    • Abdominal pain or constipation
    • Temporarily elevated liver values

    Ethical and Legal Aspects

    • Off-label use: If the medication is used outside approved indication, we document why.
    • GDPR and medical records: Your data is stored in systems that meet Swedish and European data protection legislation.
    • Equal care: We prioritize patients with the greatest medical needs.

    Patient Checklist Before GLP-1 Start

    • Have your laboratory tests been reviewed and documented?
    • Do you understand the dosing plan and which side effects to react to?
    • Do you know how often you need follow-up and how to contact the care team?
    • Do you have a plan for food, exercise, and possibly psychological support?
    • Have you saved contact information for doctor and dietitian in the patient portal?

    How Viktenheten Meets National Board Requirements

    • Medical assessment: Licensed physicians with specialist competence perform all initial assessments.
    • Laboratory collaboration: We have agreements with national laboratories.
    • Teamwork: Dietitians and physiotherapists are integrated in our medical records solution.
    • Digital follow-up: The patient follows their weight journey in real-time via our patient portal.
    • Quality register: All cases are included in an anonymized quality register.

    Frequently asked questions

    What is GLP-1 and why is it used for obesity?
    GLP-1 is an intestinal hormone that affects satiety and blood sugar. Medications that mimic the hormone make it easier to reduce hunger and stabilize blood sugar.
    What tests do I need to take before starting?
    We start from your current values and supplement as needed with blood tests such as HbA1c, blood lipids, liver and kidney status.
    How often do I need follow-up?
    We plan follow-ups approximately after 4, 12, and 24 weeks and supplement with digital check-ins.
    When do you pause or discontinue treatment?
    We make a new assessment in case of pregnancy, more pronounced side effects, or if goals are not achieved despite support.
    How does Viktenheten differ from other digital providers?
    We have a unified team of doctors, dietitians, and physiotherapists who share medical record information in real-time.

    Frequently asked questions

    What is GLP-1 and why is it used for obesity?
    GLP-1 is an intestinal hormone that affects satiety and blood sugar. Medications that mimic the hormone make it easier to reduce hunger and stabilize blood sugar.
    What tests do I need to take before starting?
    We start from your current values and supplement as needed with blood tests such as HbA1c, blood lipids, liver and kidney status.
    How often do I need follow-up?
    We plan follow-ups approximately after 4, 12, and 24 weeks and supplement with digital check-ins.
    When do you pause or discontinue treatment?
    We make a new assessment in case of pregnancy, more pronounced side effects, or if goals are not achieved despite support.
    How does Viktenheten differ from other digital providers?
    We have a unified team of doctors, dietitians, and physiotherapists who share medical record information in real-time.

    Ready for the Next Step?

    Our physicians help you develop a safe and evidence-based plan for medical weight treatment.

    Book doctor consultation

    Discover more

    Part of Curevo Health

    Viktenheten is part of Curevo Health, Sweden’s digital specialist care platform.